Thea Energy Nets $20M to Fuel Fusion Dreamby Lilu Anderson 13.02.2024Princeton-based fusion energy company, Thea Energy, has raised $20 million in Series A funding to advance its fusion technology and ...
Life Science REIT Fully Lets Building 5 at Oxford Technology Park to WAE Technologiesby Lilu Anderson 13.02.2024Life Science REIT has fully let Building 5 at Oxford Technology Park to WAE Technologies. The move highlights the demand ...
Vibhor Steel Tubes IPO Rush: Fully Bookedby Mark Eisenberg 13.02.2024The IPO of Vibhor Steel Tubes, valued at ₹72.17 crore, was fully booked within an hour of opening, showcasing a ...
Nottingham Uni: Leading VR Education Trendby Lilu Anderson 13.02.2024The opening of a cutting-edge virtual reality teaching facility at Nottingham University revolutionizes remote learning and positions the institution at ...
Chinese Investments Reshape Oceania: PRC Influence Risingby Terry Bingman 13.02.2024Investments from the People's Republic of China (PRC) in Oceania surge to $2.72 billion, reflecting the increasing presence of Chinese ...
Connect Biopharma Welcomes James Huang: Growth Surge Aheadby Mark Eisenberg 13.02.2024Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
Beamr Imaging’s $12M Raise Boosts Video Techby John Darbie 13.02.2024Beamr Imaging, a video optimization technology company, plans to raise $12 million through a public offering. The funds will support ...
Cooper Standard: Insider Promoted Amid CFO Shuffleby Terry Bingman 12.02.2024Cooper Standard promotes Alison Nudd to Vice President and Chief Accounting Officer, strengthening financial operations for future success.
Austin’s Unit 410: Remaking Tech’s Frontier?by Lilu Anderson 12.02.2024Austin is becoming a top destination for company headquarters, with Unit 410, an engineering firm, choosing it as their base. ...
Anixa’s Ovarian Cancer Trial Progress: Promising Resultsby Terry Bingman 12.02.2024Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...